BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 46 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $40,000 | -16.7% | 12,000 | 0.0% | 0.01% | -20.0% |
Q4 2021 | $48,000 | +20.0% | 12,000 | 0.0% | 0.01% | +11.1% |
Q3 2021 | $40,000 | -13.0% | 12,000 | -0.0% | 0.01% | -18.2% |
Q2 2021 | $46,000 | 0.0% | 12,003 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $46,000 | -14.8% | 12,003 | 0.0% | 0.01% | -26.7% |
Q4 2020 | $54,000 | -73.4% | 12,003 | 0.0% | 0.02% | -78.3% |
Q3 2020 | $203,000 | +50.4% | 12,003 | 0.0% | 0.07% | +32.7% |
Q2 2020 | $135,000 | +141.1% | 12,003 | +0.0% | 0.05% | +73.3% |
Q1 2020 | $56,000 | +9.8% | 12,000 | 0.0% | 0.03% | +36.4% |
Q4 2019 | $51,000 | – | 12,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABNER HERRMAN & BROCK LLC | 239,000 | $2,679,000 | 0.48% |
EAM Investors, LLC | 81,854 | $918,000 | 0.20% |
CFO4Life Group, LLC | 12,003 | $135,000 | 0.05% |
Phoenix Holdings Ltd. | 104,782 | $1,112,000 | 0.05% |
WINTON GROUP Ltd | 118,487 | $1,328,000 | 0.03% |
Merit Financial Group, LLC | 28,731 | $322,000 | 0.03% |
HighPoint Advisor Group LLC | 13,533 | $151,000 | 0.03% |
SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 23,000 | $258,000 | 0.02% |
ETF MANAGERS GROUP, LLC | 52,216 | $579,000 | 0.02% |
IHT Wealth Management, LLC | 13,000 | $146,000 | 0.02% |